Clinical Trials in Jieyang, China
2 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Sermonix Pharmaceuticals Inc.500 enrolled222 locationsNCT05696626
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis
Head and Neck CancerRadiation-Induced Mucositis
Nanfang Hospital, Southern Medical University264 enrolled4 locationsNCT06307327
Recruiting
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
Tricuspid Regurgitation
Sun Yat-sen University3,000 enrolled7 locationsNCT06926959
Recruiting
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Head and Neck CancerNasopharyngeal CarcinomaBiomarker+1 more
Nanfang Hospital, Southern Medical University300 enrolled5 locationsNCT06307314
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805